Renal Autologous Cell Therapy in Type 2 Diabetes with Late Stage 4 Diabetes-Related Chronic Kidney Disease: Trial Design and Early Analysis.

Joseph Stavas,Bijin Thajudeen,Steven Coca,Arnold Silva,Emily Butler,Randal Detwiler,Anna Burgner

Blood purification（2023）

引用 0|浏览3

暂无评分

摘要

Trials that include patients with an eGFR of <20 mL/min/1.73 m2 are uncommon, and none to date involve autologous homologous cell-based treatments. REACT has the potential to stabilize or delay dialysis in high-risk late stage 4 DKD.

查看译文

关键词

Cell-based therapy,Chronic kidney disease,Diabetic kidney disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要